Replimune Correlations

REPL Stock  USD 10.82  0.78  6.72%   
The current 90-days correlation between Replimune Group and Kura Oncology is 0.09 (i.e., Significant diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Replimune moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Replimune Group moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Replimune Correlation With Market

Weak diversification

The correlation between Replimune Group and DJI is 0.34 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Replimune Group and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Replimune Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

Moving together with Replimune Stock

  0.72OPT OptheaPairCorr
  0.7NPCE NeuropacePairCorr
  0.68TMCI Treace Medical ConceptsPairCorr

Moving against Replimune Stock

  0.36EYEN EyenoviaPairCorr
  0.4PKX POSCO HoldingsPairCorr
  0.38NHNCF NAVER CorpPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
GOSSNVCT
KURANUVL
UTHRVTYX
GOSSASND
KURAVTYX
UTHRNUVL
  
High negative correlations   
GOSSVTYX
NVCTVTYX
PTGXUTHR
ASNDNUVL
KURANVCT
UTHRASND

Risk-Adjusted Indicators

There is a big difference between Replimune Stock performing well and Replimune Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Replimune's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
NUVL  2.06 (0.08) 0.00 (0.16) 0.00 
 3.54 
 12.24 
VTYX  3.43 (0.71) 0.00 (0.51) 0.00 
 6.88 
 27.07 
ASND  2.50  0.33  0.18 (0.63) 2.25 
 5.86 
 18.15 
UTHR  1.50 (0.18) 0.00  1.68  0.00 
 2.67 
 15.73 
NVCT  3.92  1.20  0.29  8.42  3.65 
 9.96 
 26.68 
LYRA  2.97 (0.14) 0.00 (0.51) 0.00 
 5.88 
 25.31 
KRON  1.70 (0.16) 0.00 (0.67) 0.00 
 3.19 
 12.10 
GOSS  4.70  1.10  0.24 (1.37) 4.50 
 10.38 
 36.67 
KURA  2.34 (0.48) 0.00  6.72  0.00 
 4.48 
 13.72 
PTGX  2.79  0.45  0.23 (0.37) 2.46 
 3.48 
 50.66 

Replimune Corporate Management

Colin LoveChief OfficerProfile
Christopher SarchiChief OfficerProfile
Carolyn TrottSenior AssuranceProfile
Pamela EspositoChief Business OfficerProfile
Paul BullockChief HeadProfile
MBA MAChief OfficerProfile